Lucia Moitrel Pequeno Da Silva

Mrs. Lucia Moitrel Pequeno Da Silva

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2023 in Platelets
Verified
Journal Article
Open access
DSDébora de Souza Ferreira Sávio
Débora de Souza Ferreira Sávio
LSLucia Moitrel Pequeno Da Silva
Lucia Moitrel Pequeno Da Silva
GRGabriel Guerra David Reis
Gabriel Guerra David Reis
RDRicardo Junior Denardi
Ricardo Junior Denardi
NCNatacha Costa
Natacha Costa
MMMichel Reis Messora
Michel Reis Messora
This study evaluated the potential of Leukocyte-platelet-rich fibrin (L-PRF; fixed angle centrifugation protocol), Advanced-platelet-rich fibrin (A-PRF; low-speed fixed angle centrifugation protocol), and Horizontal-platelet-rich fibrin (H-PRF; horizontal centrifugation protocol) in bone neoformation in critical size defects (CSDs) in rat calvaria. Thirty-two rats were divided into groups: Control (C), L-PRF, A-PRF, and H-PRF. 5 mm diameter CSDs were created in the animals' calvaria. Defects from group Control (C) were filled with blood clots, while defects from groups L-PRF, A-PRF, and H-PRF were filled with respective platelet-rich fibrin (PRF) membranes. L-PRF, A-PRF, and H-PRF were prepared from animal blood collection and specific centrifugation protocols. At 14 and 30 days, calcein (CA) and alizarin (AL) injections were performed, respectively. Animals were euthanized at 35 days. Microtomographic, laser confocal microscopy, and histomorphometric analyzes were performed. Data were statistically analyzed (ANOVA, Tukey, p < .05). L-PRF, A-PRF, and H-PRF groups showed higher values of bone volume (BV), newly formed bone area (NFBA), and precipitation of CA and AL than the C group (p < .05). The H-PRF group showed higher values of BV, number of trabeculae (Tb. N), NFBA, and higher precipitation of AL than the A-PRF and L-PRF groups (p < .05). Therefore, it can be concluded that: i) L-PRF, A-PRF, and H-PRF potentiate bone neoformation in CSDs in rat calvaria; ii) H-PRF demonstrated more biological potential for bone healing.

19 May 2022 in Platelets
Verified
Journal Article
Closed access
LSLucia Moitrel Pequeno Da Silva
Lucia Moitrel Pequeno Da Silva
DSDébora de Souza Ferreira Sávio
Débora de Souza Ferreira Sávio
FÁFelipe Correa de Ávila
Felipe Correa de Ávila
RVRaphael Martini Vicente
Raphael Martini Vicente
GRGabriel Guerra David Reis
Gabriel Guerra David Reis
MMMichel Reis Messora
Michel Reis Messora
The current study evaluated the healing of critical-size defects (CSD) created in rat calvaria treated with platelet concentrates produced by high-speed (Leukocyte- and Platelet-Rich Fibrin - L-PRF) and low-speed (Advanced Platelet-Rich Fibrin - A-PRF) protocols of centrifugation. Twenty-four rats were distributed into three groups: Control, L-PRF, and A-PRF. Five mm diameter CSD were created on the animals’ calvaria. The defects of the L-PRF and A-PRF groups were filled with 0.01 ml of L-PRF and A-PRF, respectively. The control group defects were filled with a blood clot only. All animals were euthanized on the 35th postoperative day. Histomorphometric and microtomographic analyses were then performed. The L-PRF and A-PRF groups had significantly higher bone volume and neoformed bone area than those of the control group and lowered bone porosity values (p < .05). No significant differences were observed between A-PRF and L-PRF groups for the analyzed parameters. Therefore, it can be concluded that i) L-PRF and A-PRF potentiated the healing of CSD in rat calvaria; ii) high and low-speed centrifugation protocols did not produce PRF matrices with different biological impacts on the amount of bone neoformation.

16 October 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
WBWanderson Thalles de Souza Braga
Wanderson Thalles de Souza Braga
UMUlli da Costa Cunha Martins
Ulli da Costa Cunha Martins
DSDébora de Souza Ferreira Sávio
Débora de Souza Ferreira Sávio
LSLucia Moitrel Pequeno Da Silva
Lucia Moitrel Pequeno Da Silva
MSMaria da Conceição Pereira Saraiva
Maria da Conceição Pereira Saraiva
MMMichel Reis Messora
Michel Reis Messora
Background: This study assessed the impact of xenogeneic bone grafts (XEN), either utilized alone or combined with autologous platelet concentrates (APCs) prepared using three different centrifugation protocols, on the healing of critical-size defects (CSDs) in rat calvaria. Methods: Forty rats were assigned to five groups (n = 8): Control, XEN, XEN + L-PRF, XEN + A-PRF, and XEN + Bio-PRF. Blood concentrates were prepared by centrifuging blood collected via cardiac puncture: L-PRF (~700 g for 12 min), A-PRF (~208 g for 14 min), and Bio-PRF (~700 g for 8 min). Defects (5 mm diameter) in the right parietal bone of each rat were filled with blood clot, XEN, or XEN combined with L-PRF, A-PRF, or Bio-PRF. Animals were euthanized 60 days post-surgery, and the calvariae were analyzed using histomorphometry and micro-CT. The percentage of mature and immature collagen fibers was analyzed using Picrosirius red staining under polarized light microscopy. Results: Groups XEN-A-PRF, XEN-L-PRF, and XEN-Bio-PRF presented higher bone volume (BV/TV) than the control group (14.35 ± 6.42%, 11.96 ± 4.68%, and 14.92 ± 3.47%, respectively, vs. 4.13 ± 2.25%; p < 0.05). These groups also presented lower bone porosity (BP) than the control group (p < 0.05). The XEN group did not show different values of BV/TV and BP compared to the control group. Only the XEN + A-PRF and XEN + Bio-PRF groups showed a higher percentage of mature collagen fibers (red color) compared to the XEN and control groups (p < 0.05). The control and XEN groups showed a higher amount of immature collagen fibers (green color) compared to the XEN + A-PRF, XEN + L-PRF, and XEN + Bio-PRF groups (p < 0.05). Conclusions: It can be concluded that CSDs treated with XEN combined with APCs presented a more favorable bone microarchitecture than untreated CSDs after a 60-day healing period. Furthermore, CSDs treated with XEN combined with A-PRF or Bio-PRF showed greater collagen maturation than those treated with XEN alone, suggesting that the centrifugation protocol used for preparing APCs may be a decisive factor for the quality of the collagen matrix in newly formed bone tissue.